Brineura Approved for Rare Genetic Illness Affecting Kids

FRIDAY, April 28, 2017 — Brineura (cerliponase alfa) has been approved by the U.S. Food and Drug Administration to treat a specific form of Batten Disease, a rare set of genetic disorders that typically begin in childhood between ages 2 and 4, the…
Source: Topamax